Visual biosensing system capable of improving sensitivity and application of visual biosensing system in detection of mycobacterium tuberculosis

By combining RPA, CRISPR/Cas12a and G4-DNA nanoenzyme technologies, a real-time detection platform without special instruments was developed to address the detection problem of Mycobacterium tuberculosis, which solved the problems of insufficient detection sensitivity and equipment dependence, and achieved high Detection effects of sensitivity, accuracy and convenience.

CN118957028APending Publication Date: 2024-11-15重庆医科大学国际体外诊断研究院
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410554772.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing Mycobacterium tuberculosis detection methods have problems such as insufficient sensitivity, long detection time, high cost and equipment dependence, especially lack of effective technical support in early screening and diagnosis.

Method used

Using RPA and CRISPR/Cas12a technology combined with G4-DNA nanoenzyme, the detection was carried out by specifically targeting the gene MTB IS1081, and the results were output using the colorimetric reaction, and an instant detection platform without special instruments was developed, which significantly improved after glycerol enhancement. detection sensitivity.

Benefits of technology

It achieves high sensitivity, accuracy and specific detection of Mycobacterium tuberculosis within 60 minutes, reducing biosafety risks, low cost and convenient, and is suitable for early screening and diagnosis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118957028A_ABST
    Figure CN118957028A_ABST
Patent Text Reader

Abstract

The invention discloses a visual biosensing system capable of improving sensitivity in the technical field of medical examination, which is mainly formed by combining G4-hemin with integrated RPA-CRISPR Cas12a, the G4-hemin is obtained by carrying out chromogenic reaction on ssDNA-hemin with a nucleotide sequence as shown in SEQ ID No.1, a reverse complementary sequence ssG4R as shown in SEQ ID No.2 is added into the integrated RPA-CRISPR Cas12a detection system as a reporter probe, and the sensitivity of the RPA-CRISPR Cas12a detection system is improved. And storing in a water bath at 95 DEG C for 5 minutes. The constructed novel DNA nano enzyme G4-hemin is combined with an integrated RPA-CRISPR / Cas 12a strategy, so that the mycobacterium tuberculosis gene is visually detected, the detection is rapid and accurate, the cost is low, and the detection convenience is greatly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medical testing, and particularly relates to a visual biosensor system with improved sensitivity and its application in the detection of Mycobacterium tuberculosis. Background Art

[0002] Mycobacterium tuberculosis, referred to as tuberculosis (TB), is the pathogen that causes tuberculosis in humans and can invade organs throughout the body, such as the lungs, kidneys, spleen and brain. 90% of pulmonary tuberculosis is caused by TB infection, which is often transmitted through the respiratory tract in the form of droplets in the air.

[0003] At present, the main methods for detecting tuberculosis bacilli include: sputum smear, acid-fast bacilli culture, molecular biology method (Xpert MTB / RIF) and immunological method (γ-interferon release assay IGRA). Among them, sputum smear is the most commonly used method, which has the advantages of easy specimen acquisition, quick and simple operation, and low price. However, it is subject to the influence of many factors such as the number of mycobacteria in sputum and the professional quality of the inspectors, and often has many shortcomings such as low positive rate and easy clinical missed detection. Compared with sputum smear, the culture method can significantly increase the detection sensitivity (this method is the gold standard for diagnosing tuberculosis bacilli), but it also has the disadvantages of too long culture time (generally 8 weeks), which affects the diagnosis and treatment of patients.

[0004] With the rapid development of testing technology, molecular biological detection technology has been widely used in clinical practice. For example, the Xpert MTB / RIF equipment and supporting reagents produced by Cepec in the United States use nested fluorescence quantitative PCR technology to detect the rpoB gene and its mutation in the MTB gene to achieve fully automatic detection of MTB nucleic acid and rifampicin resistance. It has the advantages of good specificity (can accurately distinguish MTB and NTM), high sensitivity, rapid detection (can be completed in only two hours), and is suitable for clinical samples from a variety of different sources (such as sputum, alveolar lavage fluid, lung tissue, cerebrospinal fluid, lymph nodes, joint fluid and urine); at the same time, it can detect the resistance of the first-line anti-tuberculosis drug rifampicin, providing a reliable basis for clinical medication. However, there are also high costs for instrument purchase and reagent testing, which especially hinders its promotion and application in developing countries. The interferon gamma release assay (IGRA) is to detect the gamma interferon (γ-interferon, IFN-γ) produced by T cells stimulated by MTB-specific antigens to determine whether there is MTB infection. It has high sensitivity and good specificity, and is not affected by BCG vaccination and most non-tuberculosis mycobacteria (NTM). Its main disadvantages are high testing costs and inability to distinguish between active and old tuberculosis. Summary of the invention

[0005] The present invention is intended to be based on the research of new medical testing technologies. In view of the methodological deficiencies in the current MTB infection testing, a visual biosensor system with improved sensitivity and its application and use method are provided. The entire process does not rely on any special instruments, providing technical support for the early screening, diagnosis and prognosis monitoring of tuberculosis.

[0006] Based on the summary of the hazards of Mycobacterium tuberculosis and the limitations of current Mycobacterium tuberculosis detection methods, as well as the background of molecular diagnostic technology, RPA, CRISPR technology and G4 DNA nanozyme, the present invention uses the specific targeting gene of Mycobacterium tuberculosis IS1081 as the detection target, combines RPA with CRISPR / Cas12a technology and G4-DNA nanozyme, and finally outputs the detection results in a colorimetric manner, thus developing a new platform for instant detection of Mycobacterium tuberculosis.

[0007] A visual biosensor system with improved sensitivity in the present scheme is mainly composed of G4-hemin and integrated RPA-CRISPR Cas12a. The G4-hemin is a ssDNA-hemin with a nucleotide sequence as described in SEQ ID No.1 for color development reaction, and the reverse complementary sequence ssG4R as described in SEQ ID No.2 is added as a reporter probe to the integrated RPA-CRISPR Cas12a detection system, which is stored in a 95°C water bath for 5 minutes. The ssG4R is rich in TTTT structure and is complementary to the added ssDNA-hemin.

[0008] Furthermore, the integrated RPA-CRISPR Cas12a is an integrated RPA-CRISPR Cas12a enhanced with glycerol. The sensitivity of the integrated RPA-CRISPR Cas12a enhanced with glycerol is significantly improved.

[0009] Further, the preparation process of the glycerol-enhanced integrated RPA-CRISPR Cas12a is:

[0010] Prepare component A, including 1×2.1r NEBuffer, 1 μM LbCas12a, 1 μM crRNA, 2 μM ssG4R, and 15% glycerol;

[0011] Prepare component B, which is an RPA system, including 29.5 μL 10 μL 5× LongAmp reaction buffer, 240 nM forward and reverse primers, 1 lyophilized reaction pellet, target and ddH 2 O; Based on the final assembled 20 μL one-pot system, calculate the concentration of each component;

[0012] For the one-pot method, add 10 μL of component A to the bottom of the tube, 9.5 μL of component B to the wells of the tube, and finally add 0.5 μL of 280 mM magnesium acetate.

[0013] The present invention also provides application of the visual biosensor system with improved sensitivity in the detection of Mycobacterium tuberculosis.

[0014] Further, the application is: adding the test object to the integrated RPA-CRISPR Cas12a reaction, if the target gene MTB IS1081 is present in the test object, the integrated RPA-CRISPR Cas12a is activated, ssG4R is cut, and the cut ssG4R combines with ssDNA-hemin to form an activated G4-heme complex, (34-heme complex has high oxidation catalytic activity, which can catalyze TMB to turn the solution blue; if there is no target gene, the integrated RPA-CRISPR Cas12a cannot cut ssG4R, ssDNA-hemin and its antisense molecule ssG4R complement each other to form double-stranded DNA; double-stranded DNA and G4-hemin have no peroxidase activity, and the solution remains colorless.

[0015] The working principle and beneficial technical effects of the present invention are:

[0016] The present invention provides a highly sensitive visual biosensor system, which involves combining an integrated RPA-CRISPR / Cas12a and a G4-hemin with a specific structure. The amplification of the RPA target gene improves the detection sensitivity of CRISPR / Cas 12a. The integrated RPA-CRISPR / Cas 12a reduces the reaction steps and reduces the biosafety risk. The application of 15% glycerol further improves the sensitivity of the integrated RPA-CRISPR / Cas 12a. The ssG4R single chain complementary to ssDNA-hemin is designed as a reporter probe for the RPA-CRISPR / Cas 12a reaction. This highly specific and sensitive colorimetric platform can complete the specific detection of Mycobacterium tuberculosis within 60 minutes without the need for special instruments and equipment.

[0017] If the target gene MTB IS1081 is present in the test object, RPA-CRISPR / Cas12a is activated to cut ssG4R. The cut ssG4R combines with ssG4-hemin to form an activated G4-heme complex. The G4-heme complex has high oxidative catalytic activity and can catalyze TMB to turn the solution blue. If there is no target gene, CRISPR Cas12a cannot cut ssG4R, and ssG4-hemin and its antisense molecule ssG4R complement each other to form double-stranded DNA. Double-stranded DNA has no peroxidase activity with G4, and the solution remains colorless.

[0018] By combining the constructed new DNA nanozyme G4-hemin with the glycerol-enhanced integrated RPA-CRISPR / Cas 12a strategy, a visual detection method can be used to quickly detect Mycobacterium tuberculosis genes. The detection is fast, accurate, and low-cost, greatly improving the convenience of detection. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 Shown is the flowchart of glycerol-enhanced integrated RPA-CRISPR / Cas12a and G4 DNA nanozyme for detecting Mycobacterium tuberculosis genes;

[0020] Figure 2 Shown is the gene map of designed RPA amplification of Mycobacterium tuberculosis gene;

[0021] Figure 3 Shown is a diagram of designing CRISPR / Cas12a crRNA gene screening;

[0022] Figure 4 Shown is the best additive and glycerol concentration screening diagram;

[0023] Figure 5 Shown is the optimization diagram of various conditions for sensitivity analysis of detecting Mycobacterium tuberculosis;

[0024] Figure 6 Shown is a comparison chart of sensitivity analysis for detecting Mycobacterium tuberculosis;

[0025] Figure 7 Shown is a diagram of the analysis of clinical samples for the detection of Mycobacterium tuberculosis. DETAILED DESCRIPTION

[0026] The following is further described in detail through specific implementation methods:

[0027] 1. Design and amplification of PCR, RPA primers, and crRNAs

[0028] The MTB-DNA sequence was cloned into a customized pUC57 vector, and the recombinant plasmid was used as a model for PCR amplification and CRISPR / Cas12a reaction. 2 μl (10 μM) forward and reverse primers, 10 μL 5× LongAmp reaction buffer, 1.5 μL (10 mM) dNTP, 3 μL LongAmp TaqDNA polymerase, 2 μL extracted genomic DNA (500 ng) and ddH 2 O to form 50 μL PCR premix. The reaction mixture was run in a 95°C thermocycler for 45 minutes, with 5 minutes of denaturation; 95°C, 10 seconds per cycle; 62°C, annealing for 10 seconds; 72°C, elongation for 30 seconds; 35 cycles, and the CRISPR / Cas12a trans-cutting efficiency was verified by fluorescence.

[0029] In order to further improve the reaction rate, sensitivity and convenience, the recombinase polymerase amplification technology was selected for the amplification of the target gene, and the oligonucleotide primers used to develop the RPA detection were purchased from Sangon Biotech Company.

[0030] Initial screening of primer design was performed using the TwistAmp DNA amplification kit according to the manufacturer's instructions (TwistDx, Maidenhead, UK) in a final reaction volume of 50 mL. The optimal primer sequences were determined by polyacrylamide gel electrophoresis, and in the RPA reaction, 50 μL of the premix consisted of 2.4 μL (10 μM) forward and reverse primers, 29.5 μL TwistAmp Exo buffer, 2.5 μL 280 mM MgOAc, 2 μL extracted genomic DNA, and 10.2 μL ddHO. 2 O composition.

[0031] According to the CRISPR / Cas 12a reaction principle, the 17 bases after the TTTN / TTN protospacer adjacent motif (PAM) sequence in MTB IS1081 should be used as targets for species detection. The fluorescent probe is a single-stranded DNA probe modified by a luminescent group and a quenching group, with a FAM label at the 5′ end and a BHQ1 label at the 3′ end (FAM-TTATT-BHQ1).

[0032] 2. Design of DNA nanozyme colorimetric reaction

[0033] In this study, a visualization system was established based on the peroxidase activity of G4-hemin DNA nanozyme. The DNA nanozyme ssDNA-hemin (whose sequence is hemin-TGGGTAGGGCGGGTTGGGAAA-3′, SEQ ID No.1) was selected for color development. The reverse complementary sequence ssG4R (5′-TTTCCCAACCCGCCCTACCCA-3′, SEQ ID No.2) was added to the integrated RPA-CRISPR / Cas12a detection system as a reporter probe, and the CRISPR / Cas12a reaction was performed according to the above method. 20 μL of the above Cas12a reaction product was mixed with 2 μL of ssDNA-hemin (20 μM) solution, stored in a 95 ° C water bath for 5 minutes, and then cooled to room temperature to anneal the DNA nanozyme (ssDNA-hemin) and the probe (ssG4R). Then, after fully adding 100 μL of 3,3,5,5-tetramethylbenzidine (TMB), it was added for color development. After 5 minutes, a distinct blue color appears, indicating the presence of target DNA, while the negative solution without target DNA is colorless or light blue.

[0034] 3. Glycerol-enhanced All-in-One RPA-CRISPR / Cas12a Analysis

[0035] In order to shorten the detection time and eliminate the dependence on power equipment, RPA replaced the traditional PCR method. RPA primers were designed according to the detection design instructions of the TwistAmp DNA amplification kit. In order to improve the amplification speed and sensitivity of the reaction, the expected length of the amplification product was designed to be 200 bp. The GC content of the designed primers was 20% to 60%, the length was 32 nucleotides, and there was no obvious complementary sequence or palindrome. The RPA primers and reaction system are detailed in Table S1.

[0036] Table S1: RPA primers and reaction system

[0037]

[0038] The one-pot system was prepared into component A and component B. Component A contained 1×2.1rNEBuffer, 1μM LbCas12a, 1μM crRNA, 2μM ssC4R, and 15% glycerol. Component B was the RPA system, including 29.5μL10μL 5×LongAmp reaction buffer, 240nM forward and reverse primers, 1 lyophilized reaction pellet, target, and ddH 2 O. Based on the final assembled 20 μL one-pot system, the concentrations of each component were calculated. One-pot method: add 10 μL of component A to the bottom of the tube, 9.5 μL of component B to the well of the tube, and finally add 0.5 μL of 280 mM magnesium acetate. For the all-in-one RPA-CRISPR / Cas12a assay, all reactions were performed at 37°C for 60 minutes.

[0039] 4. Optimization of various conditions in the detection system.

[0040] The DNA nanozyme G4-hemin coupled with the glycerol-enhanced integrated RPA-CRISPR / Cas12a method is an enzymatic reaction, and its detection ability is closely related to parameters such as reaction time, temperature, buffer, enzyme concentration, and Cas12a protein. In order to achieve the best detection effect, we optimized and evaluated the detection-related conditions by the end-point fluorescence intensity. Here, we performed the detection at 35°C, 37°C, 39°C, 42°C, and 45°C from 20 to 100 minutes, and the fluorescence signal value reached the maximum value at 60 minutes and 37°C ( Figure 5 A and H). Then three different buffers were selected (2.1r buffer, 3.1r buffer, Cutsmart buffer), and the results showed that the fluorescence signal values ​​of different buffers reached peak values, and 2.1r buffer was selected as the best ( Figure 5B). The concentrations of Cas12a protein, crRNA, MgOAc, primers, and ssG4R were optimized by detecting the fluorescence intensity. The results showed that as the concentration of Cas12a increased, the fluorescence signal value reached a peak. Therefore, 1 μM Cas12a was selected as the optimal reaction concentration ( Figure 5 C), 1 μM crRNA, 28 mM MgOAc, 0.24 μM RPA primer and 2 μM ssG4R were selected as the optimal reaction conditions for subsequent experiments ( Figure 5 D, 5E, 5F, 5I).

[0041] 5. Sensitivity evaluation of the integrated RPA-CRISPR / Cas12a method enhanced by DNA nanozyme and glycerol

[0042] As described in this study, glycerol greatly improved the detection efficiency of the glycerol-enhanced integrated RPA-CRISPR / Cas12a system with the DNA nanozyme G4-hemin. Here, the analytical sensitivity was further confirmed by using serial dilutions of TB DNA ( Figure 6 A), and found that the detection limit clearly reached 1copy / μL ( Figure 6 B) Using different concentrations of synthetic target gene fragments to evaluate analytical performance ( Figure 6 C). As the concentration of the target gene fragment increases, the color change after reaction with TMB gradually increases. We further want to know whether its sensitivity can be compared with the standard four-step detection method, and we determined the sensitivity of the latter. The detection limit of the four-step method is also 1copy / μL ( Figure 6 E) That is, the glycerol-enhanced one-pot method has the same analytical sensitivity as the four-step method.

[0043] 6. Clinical Sample Analysis and Specificity of Biosensor Systems for Tuberculosis Detection

[0044] The DNA nanozyme combined with glycerol-enhanced integrated RPA-CRISPR / Cas12a method has good sensitivity, specificity and accuracy in detecting Mycobacterium tuberculosis DNA. The MTB IS1081 gene and MTB IS6110 were selected as gene loci for MTB detection. To verify the specificity of this method, we used MTB IS6110 and some human respiratory viruses (Haemophilus influenzae, Streptococcus pneumoniae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Mycoplasma pneumoniae) for detection. The results showed that both genetic tests had no cross-reaction with other DNA viruses ( Figure 7 A, D). Secondly, to further verify its practical application, 104 samples were measured. As expected, the method clearly identified 84 infected samples and 20 healthy samples from the samples ( Figure 7B, E). This method has 100% accuracy and good specificity in the clinical detection of MTB.

[0045] Example: Glycerol-enhanced integrated RPA-CRISPR / Cas12a and G4 DNA nanozyme for detecting Mycobacterium tuberculosis genes

[0046] 1. DNA nanozymes exhibit peroxidase-like activity and can undergo color development under mild conditions, making CRISPR detection easy to visualize.

[0047] The optimized integrated RPA-CRISPR / Cas12a method is combined with the DNA nanozyme G4-hemin, and the catalytic activity of the DNA nanozyme G4-hemin is used to output the target detection results. In this process, no special equipment is required at any time, and the results are visible to the naked eye. The excellent colorimetric reaction performance of the DNA nanozyme G4-hemin not only reduces the cost of CRISPR / Cas12a-based detection and diagnostic signal output, but also increases the convenience of the detection system. Figure 1 As shown, after Cas12a cleaves ssG4R, adding ssDNA-hemin nucleic acid can form an activated G4-heme complex at 95°C, which catalyzes TMB and turns the solution blue. If Cas12a fails to cut ssG4R, ssDNA-hemin and its antisense molecule ssG4R complement each other to form double-stranded DNA; the G4-heme complex fails to form, there is no peroxidase activity, and the solution remains unchanged, indicating that there is no target gene.

[0048] 2. Design and screening of RPA primers

[0049] We selected MTB IS1081 (Gene ID: 32286187, 4 / 24 / 2020). In order to shorten the detection time and eliminate the dependence on power equipment, the traditional PCR method was changed to RPA. The RPA primers were designed according to the instructions in the detection design manual of the TwistAmp DNA amplification kit. The expected length of the amplified product was designed to be between 200bp. The GC content of the designed primers was 20%-60%, the design length was 32bp, and there was no obvious complementary sequence and palindrome. Figure 2 shown.

[0050] 3. crRNA design and screening

[0051] The 17 bases following the TTTN / TTN protospacer adjacent motif (PAM) sequence in MTB IS1081 can serve as a target site for CRISPR trans-cleavage activity activation, see Figure 3 .

[0052] 4. How to enhance integrated RPA-CRISPR / Cas12a

[0053] Previous studies have shown that some additives can improve the efficiency of nucleic acid detection. For example, betaine, dimethyl sulfoxide (DMSO), glycerol, and γ-aminobutyric acid (GABA) have been shown to accelerate PCR or isotherm amplification. Recent studies have also shown that betaine, DMSO, and glycerol promote production efficiency. Considering the poor sensitivity of the traditional one-pot RPA-CRISPR detection system, here we tried to screen some additives that can improve the detection efficiency. In the present invention, we evaluated the effects of five additives (DMSO, betaine, GABA, taurine, and glycerol) on the one-pot RPA-CRISPR reaction system ( Figure 4 A). We found that glycerol significantly improved the detection efficiency. Furthermore, the enhancement was observed to be dependent on the glycerol concentration, with the enhancement being optimal at 15% glycerol ( Figure 4 B).

[0054] 5. Evaluation of the analytical sensitivity of the glycerol-enhanced one-pot RPA-CRISPR Cas12a method

[0055] In this study, we concluded that glycerol significantly improved the detection sensitivity of the all-in-one RPA-CRISPR Cas12a system. The sensitivity of the assay was further confirmed here by serial dilutions of TB DNA ( Figure 6 A), and found that the detection limit clearly reached 1copy / μL ( Figure 6 B). Different concentrations of synthetic target gene fragments were used to evaluate the analytical performance ( Figure 6 C). The color change increases with the concentration of the target gene fragment. We further wondered whether its sensitivity could be comparable to that of the classical two-step assay and determined the sensitivity of the latter ( Figure 6 D). The results showed that the detection limit of the two-step method was also 1 copy / μL ( Figure 6 E). That is, the glycerol-enhanced one-pot method achieved the same excellent analytical sensitivity as the two-step method.

[0056] 6. Clinical samples of biosensors for tuberculosis detection

[0057] Glycerol-enhanced integrated PRA-CRISPR / Cas12a combined with G4-hemin has excellent sensitivity, specificity and accuracy in detecting tuberculosis DNA. The MTB IS1081 gene and MTB IS6110 were selected as gene loci for MTB detection. To demonstrate its specificity, we performed this method using DNA input from other MTBIS6110 and some human respiratory viruses (Haemophilus influenzae, Streptococcus pneumoniae, Klebsiella pneumoniae, pathogenic fungi Pseudomonas, Mycoplasma pneumoniae). The results showed that there was no cross-reactivity with other DNA viruses in both genetic tests ( Figure 7 A, D). Next, to further verify its practical application, we tested 104 samples. As expected, the method clearly identified 84 infected samples and 20 healthy samples from the samples ( Figure 7 B, E). In conclusion, this method has 100% accuracy in clinical application for the detection of Mycobacterium tuberculosis.

Claims

1. A visual biosensor system with improved sensitivity, characterized in that: The biosensor system is mainly composed of G4-hemin and integrated RPA-CRISPR / Cas12a. The G4-hemin is a ssDNA-hemin with a nucleotide sequence as described in SEQ ID No.1 for color development reaction. The reverse complementary sequence ssG4R as described in SEQ ID No.2 is added as a reporter probe to the integrated RPA-CRISPR / Cas12a detection system and stored in a 95°C water bath for 5 minutes. The ssG4R is rich in TTTT structure and is complementary to the added ssDNA-hemin.

2. A visual biosensor system with improved sensitivity according to claim 1, characterized in that: The integrated RPA-CRISPR / Cas12a is an integrated RPA-CRISPR / Cas12a enhanced with glycerol.

3. A visual biosensor system with improved sensitivity according to claim 2, characterized in that: The preparation process of the glycerol-enhanced integrated RPA-CRISPR / Cas12a is: Prepare component A, including 1×2.1r NEBuffer, 1 μM LbCas12a, 1 μM crRNA, 2 μM ssG4R, and 15% glycerol; Prepare component B, which is an RPA system, including 29.5 μL 10 μL 5×LongAmp reaction buffer, 240 nM forward and reverse primers, 1 lyophilized reaction pellet, target and ddH2O; calculate the concentration of each component based on the final assembled 20 μL one-pot system; For the one-pot method, add 10 μL of component A to the bottom of the tube, 9.5 μL of component B to the wells of the tube, and finally add 0.5 μL of 280 mM magnesium acetate.

4. Use of a visual biosensor system with improved sensitivity according to any one of claims 1 to 3 in the detection of Mycobacterium tuberculosis.

5. The use according to claim 4, characterized in that: The test object is added to the integrated RPA-CRISPR / Cas12a reaction. If the target gene MTB IS1081 is present in the test object, the integrated RPA-CRISPR / Cas12a is activated and ssG4R is cut. The cut ssG4R combines with ssDNA-hemin to form an activated G4-heme complex. The G4-heme complex has high oxidative catalytic activity and can catalyze TMB to turn the solution blue. If there is no target gene, the integrated RPA-CRISPR / Cas12a cannot cut ssG4R, and ssDNA-hemin and its antisense molecule ssG4R complementarily pair to form double-stranded DNA; Double-stranded DNA and G4-hemin have no peroxidase activity and the solution remains colorless.